Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for 3'-Sialyllactose.
3'-Sialyllactose is a primary human milk oligosaccharide that functions as a prebiotic substrate for Bifidobacterium species and acts as a decoy receptor for enteric pathogens while providing essential sialic acid for neonatal neurodevelopment and systemic immune modulation.
110661
182.26 g/mol
3.1
(1,3,3-trimethyl-2-bicyclo[2.2.1]heptanyl) formate
Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for 3'-Sialyllactose across standard consumer modalities.
The high hygroscopicity of 3'-Sialyllactose requires moisture-resistant HPMC capsules and desiccants to prevent clumping and degradation.
The presence of reducing sugar moieties in 3'-Sialyllactose poses a risk of Maillard browning and texture degradation during high-temperature pectin setting.
The high efficacious dose of 3'-Sialyllactose typically exceeds the 50mg payload capacity of standard thin-film polymer matrices.
Ready to launch a product featuring 3'-Sialyllactose? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.
Build Science-Backed FormulationNeed absolute proof that your 3'-Sialyllactose extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.
Simulate BioavailabilityIs your 3'-Sialyllactose payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.
Model Active Degradation